Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
FundRx, also known as MBX Capital, is an early-stage venture capital firm based in New York, NY, and Washington, D.C. The firm focuses on supporting founders in the healthcare sector, particularly those developing deep health innovations. FundRx manages a portfolio of 20 companies and collaborates with co-investors to advance healthcare technology.
FundRx invests in early-stage companies within the deep health sector, emphasizing advancements in healthcare technology and services. Their investment strategy includes a focus on drug formulation, chronic disease detection, genetic testing, and mental healthcare. Typical investment stages include pre-seed, seed, and seed-plus, with a commitment to innovative healthcare solutions.
Notable portfolio companies include Persist AI, which utilizes AI and robotics for faster drug formulation screening; Juniper, specializing in preimplantation genetic testing for IVF; and Journey Colab, focused on psychedelic therapies for addiction. Other companies include Mae Health, addressing maternal health gaps, and Vaxxinity, which develops synthetic peptide vaccines for chronic diseases.
Submit your pitch through their form at https://www.mbxcapital.com.
FundRx often leads investment rounds, particularly in early-stage companies within their focus areas.
FundRx is open to follow-on investments, especially for companies that align with their deep health thesis and demonstrate significant progress.
Specific fund size details are not disclosed, but FundRx actively manages a portfolio of 20 companies across various stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.